Brussels, 20/01/2005 (Agence Europe) - In the context of the Full Market Approval (FMA) procedure, twenty “new” medicines obtained FMA granted by the European Commission in 2004, whereas last year in the USA only fourteen medicines obtained FMA. An encouraging result of the European Medicines Agency, which in seven cases gave its approval in the same year as the Federal Drugs Administration (for one of these products, the Commission was unable to grant approval by the end of the year)....